Literature DB >> 33738254

The NEAT1_2/miR-491 Axis Modulates Papillary Thyroid Cancer Invasion and Metastasis Through TGM2/NFκb/FN1 Signaling.

Wei Sun1, Yuan Qin1, Zhihong Wang1, Wenwu Dong1, Liang He1, Ting Zhang1, Hao Zhang1.   

Abstract

NEAT1 (nuclear paraspeckle assembly transcript 1) is an oncogenic long non-coding RNA (lncRNA) that facilitates tumorigenesis in multiple cancers. In papillary thyroid cancer (PTC), the molecular mechanism by which NEAT1 affects invasion and metastasis remains elusive. RNA sequencing was used to discover differentially expressed NEAT1_2 downstream genes. Protein and RNA expression analyses and immunohistochemistry detected the expression of NEAT1_2, Transglutaminase 2 (TGM2), and microRNA-491 (miR-491) among PTC and non-cancerous tissues. Transwell and wound healing assays, and a mouse model of lung metastasis were used for further functional analyses. Bioinformatics was performed to predict miRNAs binding to both NEAT1_2 and TGM2. Rescue experiments and dual-luciferase reporter assays were performed. In PTC tissues, NEAT1_2 expression was markedly increased and regulated TGM2 expression. TGM2 was overexpressed in PTC, correlating positively with exthyroidal extension and lymph node metastasis. TGM2 knockdown significantly inhibited invasion and metastasis. NEAT1_2 sponged miR-491, acting as a competing endogenous RNA to regulate TGM2 expression. Fibronectin 1 (FN1) was predicted as a TGM2 target. TGM2 could transcriptionally activate FN1 by promoting nuclear factor kappa B (NFκb) p65 nuclear translocation, ultimately promoting PTC invasion/metastasis. These findings identify that NEAT1_2 sponges miR-491 to regulate TGM2 expression. TGM2 activates FN1 via NFκb to promote PTC invasion and metastasis.
Copyright © 2021 Sun, Qin, Wang, Dong, He, Zhang and Zhang.

Entities:  

Keywords:  FN1; NEAT1_2; TGM2; lncRNA; papillary thyroid cancer

Year:  2021        PMID: 33738254      PMCID: PMC7960914          DOI: 10.3389/fonc.2021.610547

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  8 in total

1.  Reply to Letter to the Editor: Identification of MSC‑AS1, a novel lncRNA for the diagnosis of laryngeal cancer.

Authors:  Yudong Liu; Baoshan Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-10       Impact factor: 2.503

2.  Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer.

Authors:  Haiou Yu; Shuang Luo
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

3.  Identification of Prognostic Biomarkers of Glioblastoma Based on Multidatabase Integration and Its Correlation with Immune-Infiltration Cells.

Authors:  Wencong Ding; Xian Zhou; Guoqiang Jiang; Weiwei Xu; Songkai Long; Fan Xiao; Yongshi Liao; Jia Liu
Journal:  J Oncol       Date:  2022-05-31       Impact factor: 4.501

4.  A Positive Feedback Loop of lncRNA MIR31HG-miR-361-3p -YY1 Accelerates Colorectal Cancer Progression Through Modulating Proliferation, Angiogenesis, and Glycolysis.

Authors:  Tao Guo; Defeng Liu; Shihao Peng; Meng Wang; Yangyang Li
Journal:  Front Oncol       Date:  2021-08-17       Impact factor: 6.244

5.  BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma.

Authors:  Xing Chen; Shan Lin; Ying Lin; Songsong Wu; Minling Zhuo; Ailong Zhang; Junjie Zheng; Zhenhui You
Journal:  J Transl Med       Date:  2022-02-05       Impact factor: 5.531

6.  A Comprehensive Risk Assessment and Stratification Model of Papillary Thyroid Carcinoma Based on the Autophagy-Related LncRNAs.

Authors:  Yongrun Mu; Fuling Song; Kai Yuan; Zili Zhang; Yan Lu; Rongzhan Fu; Dongsheng Zhou
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 7.  Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer.

Authors:  Jingtao Gu; Bo Zhang; Rui An; Weikun Qian; Liang Han; Wanxing Duan; Zheng Wang; Qingyong Ma
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

8.  Potential biomarkers and immune characteristics of small bowel adenocarcinoma.

Authors:  Jinggao Feng; Xiayu Tang; Liusong Song; Zhipeng Zhou; Yuan Jiang; Yao Huang
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.